Concepedia

Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy

Victor L. Serebruany, Alex I. Malinin, Kevin P. Callahan, Azan S. Binbrek, Frans Van de Werf, John H. Alexander, Christopher B. Granger, Paul A. Gurbel

American Heart Journal · 2003 · 33 citations · 35 references

DOI

Concepts

References

35

ACC/AHA guidelines for the management of patients with acute myocardial infarction

Jeffrey L. Anderson, Elliott M. Antman, Blaine A. Braniff et al. · Journal of the American College of Cardiology · 1996 · 1.9K citations

, , +14

Platelet Activation in Unstable Coronary Disease

Desmond J. Fitzgerald, Louis Roy, Francesca Catella et al. · New England Journal of Medicine · 1986 · 1.1K citations

, , +16

Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

L.A. Erickson, Mark H. Ginsberg, David J. Loskutoff · Journal of Clinical Investigation · 1984 · 360 citations · Full text

, , +15

Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and Thrombomodulin

Karlheinz Peter, Peter P. Nawroth, Christian Conradt et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1997 · 306 citations

, , +14

More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction

Richard W. Smalling, Christoph Bode, John M. Kalbfleisch et al. · Circulation · 1995 · 287 citations

, , +10